;PMID: 1384545
;source_file_1767.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..66] = [t:0..66]
;1)sentence:[e:72..187] = [t:72..187]
;2)section:[e:191..211] = [t:191..211]
;3)section:[e:215..264] = [t:215..264]
;4)section:[e:268..300] = [t:268..300]
;5)sentence:[e:304..667] = [t:304..667]
;6)sentence:[e:668..787] = [t:668..787]
;7)section:[e:791..835] = [t:791..835]

;section 0 Span:0..66
;Zhongguo Zhong Yao Za Zhi. 1992 Apr;17(4):233-6, inside backcover.
(SEC
  (FRAG (NNP:[0..8] Zhongguo) (NNP:[9..14] Zhong) (NNP:[15..18] Yao)
        (NNP:[19..21] Za) (NNP:[22..25] Zhi) (.:[25..26] .) (CD:[27..31] 1992)
        (.:[32..39] Apr;17-LRB-) (CD:[39..40] 4) (-RRB-:[40..41] -RRB-)
        (::[41..42] :) (CD:[42..45] 233) (JJ:[45..47] -6) (,:[47..48] ,)
        (IN:[49..55] inside) (RB:[56..65] backcover) (.:[65..66] .)))

;sentence 1 Span:72..187
;[Mechanisms of protective action of radix Salviae miltiorrhizae (RSM) against
; experimental hepatic injury in rats]
;[108..135]:substance:"radix Salviae miltiorrhizae"
;[137..140]:substance:"RSM"
(SENT
  (NP-HLN (-LRB-:[72..73] -LSB-)
    (NP (NNS:[73..83] Mechanisms))
    (PP (IN:[84..86] of)
      (NP
        (NP (JJ:[87..97] protective) (NN:[98..104] action))
        (PP (IN:[105..107] of)
          (NP
            (NP (NN:[108..113] radix) (NNP:[114..121] Salviae)
                (NNP:[122..135] miltiorrhizae))
            (NP (-LRB-:[136..137] -LRB-) (NN:[137..140] RSM)
                (-RRB-:[140..141] -RRB-))))))
    (PP (IN:[142..149] against)
      (NP (JJ:[151..163] experimental) (JJ:[164..171] hepatic)
          (NN:[172..178] injury)))
    (PP-LOC (IN:[179..181] in)
      (NP (NNS:[182..186] rats)))
    (-RRB-:[186..187] -RSB-)))

;section 2 Span:191..211
;[Article in Chinese]
(SEC
  (FRAG (-LRB-:[191..192] -LSB-) (NN:[192..199] Article) (IN:[200..202] in)
        (JJ:[203..210] Chinese) (.:[210..211] -RSB-)))

;section 3 Span:215..264
;Deng H, Ma X, Xu R, Chen X, Zhao Y, Yin L, Han D.
(SEC
  (FRAG (NNP:[215..219] Deng) (NNP:[220..222] H,) (NNP:[223..225] Ma)
        (NNP:[226..227] X) (,:[227..228] ,) (NNP:[229..231] Xu)
        (NNP:[232..233] R) (,:[233..234] ,) (NNP:[235..239] Chen)
        (NNP:[240..241] X) (,:[241..242] ,) (NNP:[243..247] Zhao)
        (NNP:[248..249] Y) (,:[249..250] ,) (NNP:[251..254] Yin)
        (NNP:[255..257] L,) (NNP:[258..261] Han) (NNP:[262..264] D.)))

;section 4 Span:268..300
;Shanxi Medical College, Taiyuan.
(SEC
  (FRAG (NNP:[268..274] Shanxi) (NNP:[275..282] Medical)
        (NNP:[283..290] College) (,:[290..291] ,) (NNP:[292..299] Taiyuan)
        (.:[299..300] .)))

;sentence 5 Span:304..667
;The results indicated that RSM could significantly inhibit the lipid 
;peroxidation of normal livers and cultured hepatocytes of rats, induce liver 
;microsomal cytochrome P450 in normal rats, increase nucleic acids, proteins, 
;urea and cerolloplasmin of damaged cultured hepatocytes of rats, relieve 
;ultrastructural damage of cultured hepatocytes induced by CCl4.
;[331..334]:substance:"RSM"
;[367..372]:substance:"lipid"
;[463..478]:cyp450:"cytochrome P450"
;[504..517]:substance:"nucleic acids"
;[519..527]:substance:"proteins"
;[530..534]:substance:"urea"
;[539..553]:substance:"cerolloplasmin"
;[662..666]:substance:"CCl4"
(SENT
  (S
    (NP-SBJ (DT:[304..307] The) (NNS:[308..315] results))
    (VP (VBD:[316..325] indicated)
      (SBAR (IN:[326..330] that)
        (S
          (NP-SBJ (NN:[331..334] RSM))
          (VP (MD:[335..340] could)
            (VP
              (VP
                (ADVP (RB:[341..354] significantly))
                (VB:[355..362] inhibit)
                (NP
                  (NP (DT:[363..366] the) (NN:[367..372] lipid)
                      (NN:[374..386] peroxidation))
                  (PP (IN:[387..389] of)
                    (NP
                      (NP
                        (NP (JJ:[390..396] normal) (NNS:[397..403] livers))
                        (CC:[404..407] and)
                        (NP (VBN:[408..416] cultured)
                            (NNS:[417..428] hepatocytes)))
                      (PP (IN:[429..431] of)
                        (NP (NNS:[432..436] rats)))))))
              (,:[436..437] ,)
              (VP (VB:[438..444] induce)
                (NP (NN:[445..450] liver) (JJ:[452..462] microsomal)
                   (NN:[463..473] cytochrome) (NN:[474..478] P450))
                (PP-LOC (IN:[479..481] in)
                  (NP (JJ:[482..488] normal) (NNS:[489..493] rats))))
              (,:[493..494] ,)
              (VP (VB:[495..503] increase)
                (NP
                  (NP
                    (NP (JJ:[504..511] nucleic) (NNS:[512..517] acids))
                    (,:[517..518] ,)
                    (NP (NNS:[519..527] proteins))
                    (,:[527..528] ,)
                    (NP (NN:[530..534] urea))
                    (CC:[535..538] and)
                    (NP (NN:[539..553] cerolloplasmin)))
                  (PP (IN:[554..556] of)
                    (NP
                      (NP (VBN:[557..564] damaged) (VBN:[565..573] cultured)
                          (NNS:[574..585] hepatocytes))
                      (PP (IN:[586..588] of)
                        (NP (NNS:[589..593] rats)))))))
              (,:[593..594] ,)
              (VP (VB:[595..602] relieve)
                (NP
                  (NP (JJ:[604..619] ultrastructural) (NN:[620..626] damage))
                  (PP (IN:[627..629] of)
                    (NP (VBN:[630..638] cultured) (NNS:[639..650] hepatocytes)))
                  (VP (VBN:[651..658] induced)
                    (NP (-NONE-:[658..658] *))
                    (PP (IN:[659..661] by)
                      (NP-LGS (NN:[662..666] CCl4)))))))))))
    (.:[666..667] .)))

;sentence 6 Span:668..787
;The  pharmacological actions mentioned above should be considered as
;important  mechanisms of RSM against liver injury.
;[762..765]:substance:"RSM"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[668..671] The) (JJ:[673..688] pharmacological)
          (NNS:[689..696] actions))
      (VP (VBN:[697..706] mentioned)
        (NP (-NONE-:[706..706] *))
        (ADVP (RB:[707..712] above))))
    (VP (MD:[713..719] should)
      (VP (VB:[720..722] be)
        (VP (VBN:[723..733] considered)
          (NP-1 (-NONE-:[733..733] *))
          (PP (IN:[734..736] as)
            (NP
              (NP (JJ:[737..746] important) (NNS:[748..758] mechanisms))
              (PP (IN:[759..761] of)
                (NP (NN:[762..765] RSM)))
              (PP (IN:[766..773] against)
                (NP (NN:[774..779] liver) (NN:[780..786] injury))))))))
    (.:[786..787] .)))

;section 7 Span:791..835
;PMID: 1384545 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[791..795] PMID) (::[795..796] :) (CD:[797..804] 1384545)
        (NN:[805..806] -LSB-) (NNP:[806..812] PubMed) (::[813..814] -)
        (NN:[815..822] indexed) (IN:[823..826] for)
        (NNP:[827..835] MEDLINE-RSB-)))
